Literature DB >> 23697369

Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets.

Daniel Arango1, Kengo Morohashi, Alper Yilmaz, Kouji Kuramochi, Arti Parihar, Bledi Brahimaj, Erich Grotewold, Andrea I Doseff.   

Abstract

Flavonoids constitute the largest class of dietary phytochemicals, adding essential health value to our diet, and are emerging as key nutraceuticals. Cellular targets for dietary phytochemicals remain largely unknown, posing significant challenges for the regulation of dietary supplements and the understanding of how nutraceuticals provide health value. Here, we describe the identification of human cellular targets of apigenin, a flavonoid abundantly present in fruits and vegetables, using an innovative high-throughput approach that combines phage display with second generation sequencing. The 160 identified high-confidence candidate apigenin targets are significantly enriched in three main functional categories: GTPase activation, membrane transport, and mRNA metabolism/alternative splicing. This last category includes the heterogeneous nuclear ribonucleoprotein A2 (hnRNPA2), a factor involved in splicing regulation, mRNA stability, and mRNA transport. Apigenin binds to the C-terminal glycine-rich domain of hnRNPA2, preventing hnRNPA2 from forming homodimers, and therefore, it perturbs the alternative splicing of several human hnRNPA2 targets. Our results provide a framework to understand how dietary phytochemicals exert their actions by binding to many functionally diverse cellular targets. In turn, some of them may modulate the activity of a large number of downstream genes, which is exemplified here by the effects of apigenin on the alternative splicing activity of hnRNPA2. Hence, in contrast to small-molecule pharmaceuticals designed for defined target specificity, dietary phytochemicals affect a large number of cellular targets with varied affinities that, combined, result in their recognized health benefits.

Entities:  

Keywords:  FRET; cancer; inflammation; nanosensor

Mesh:

Substances:

Year:  2013        PMID: 23697369      PMCID: PMC3683737          DOI: 10.1073/pnas.1303726110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex.

Authors:  A Krueger; I Schmitz; S Baumann; P H Krammer; S Kirchhoff
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

Review 2.  Dietary phenolics: chemistry, bioavailability and effects on health.

Authors:  Alan Crozier; Indu B Jaganath; Michael N Clifford
Journal:  Nat Prod Rep       Date:  2009-05-13       Impact factor: 13.423

Review 3.  Nutritional systems biology: definitions and approaches.

Authors:  Gianni Panagiotou; Jens Nielsen
Journal:  Annu Rev Nutr       Date:  2009       Impact factor: 11.848

Review 4.  Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors.

Authors:  Mohamed Aittaleb; Cassandra A Boguth; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2009-10-30       Impact factor: 4.436

Review 5.  Death and anti-death: tumour resistance to apoptosis.

Authors:  Frederik H Igney; Peter H Krammer
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

Review 6.  Flavonoids as developmental regulators.

Authors:  Loverine P Taylor; Erich Grotewold
Journal:  Curr Opin Plant Biol       Date:  2005-06       Impact factor: 7.834

7.  hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung.

Authors:  Shulin Wu; Masami Sato; Chiaki Endo; Akira Sakurada; Boming Dong; Hirokazu Aikawa; Yan Chen; Yoshinori Okada; Yuhji Matsumura; Eisaburo Sueoka; Takashi Kondo
Journal:  Lung Cancer       Date:  2003-08       Impact factor: 5.705

8.  Identification of small molecule binding molecules by affinity purification using a specific ligand immobilized on PEGA resin.

Authors:  Kouji Kuramochi; Yuka Miyano; Yoshihiro Enomoto; Ryo Takeuchi; Kazutomo Ishi; Yoichi Takakusagi; Takeki Saitoh; Keishi Fukudome; Daisuke Manita; Yoshifumi Takeda; Susumu Kobayashi; Kengo Sakaguchi; Fumio Sugawara
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

9.  Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.

Authors:  Eun Jeong Choi; Gun-Hee Kim
Journal:  J Nutr Biochem       Date:  2008-07-24       Impact factor: 6.048

10.  Apigenin-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27.

Authors:  M E Gonzalez-Mejia; O H Voss; E J Murnan; A I Doseff
Journal:  Cell Death Dis       Date:  2010-08-19       Impact factor: 8.469

View more
  40 in total

1.  Dietary apigenin reduces LPS-induced expression of miR-155 restoring immune balance during inflammation.

Authors:  Daniel Arango; Mayra Diosa-Toro; Laura S Rojas-Hernandez; Jessica L Cooperstone; Steven J Schwartz; Xiaokui Mo; Jinmai Jiang; Thomas D Schmittgen; Andrea I Doseff
Journal:  Mol Nutr Food Res       Date:  2015-02-23       Impact factor: 5.914

Review 2.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

3.  Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells.

Authors:  Pantipa Subhasitanont; Daranee Chokchaichamnankit; Khajeelak Chiablaem; Siriporn Keeratichamroen; Lukana Ngiwsara; N Monique Paricharttanakul; Kriengsak Lirdprapamongkol; Churat Weeraphan; Jisnuson Svasti; Chantragan Srisomsap
Journal:  Oncol Lett       Date:  2017-08-02       Impact factor: 2.967

4.  Apigenin alleviates STZ-induced diabetic cardiomyopathy.

Authors:  Huang-Jun Liu; Yun-Lin Fan; Hai-Han Liao; Yuan Liu; Si Chen; Zhen-Guo Ma; Ning Zhang; Zheng Yang; Wei Deng; Qi-Zhu Tang
Journal:  Mol Cell Biochem       Date:  2017-02-07       Impact factor: 3.396

5.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

6.  Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells.

Authors:  Ivana Vrhovac Madunić; Josip Madunić; Maja Antunović; Mladen Paradžik; Vera Garaj-Vrhovac; Davorka Breljak; Inga Marijanović; Goran Gajski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-14       Impact factor: 3.000

7.  Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids.

Authors:  Bhaskar Kahali; Stefanie B Marquez; Kenneth W Thompson; Jinlong Yu; Sarah J B Gramling; Li Lu; Aaron Aponick; David Reisman
Journal:  Carcinogenesis       Date:  2014-05-29       Impact factor: 4.944

8.  The Identification of Maize and Arabidopsis Type I FLAVONE SYNTHASEs Links Flavones with Hormones and Biotic Interactions.

Authors:  María Lorena Falcone Ferreyra; Julia Emiliani; Eduardo José Rodriguez; Valeria Alina Campos-Bermudez; Erich Grotewold; Paula Casati
Journal:  Plant Physiol       Date:  2015-08-12       Impact factor: 8.340

9.  Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications.

Authors:  Ximena Paredes-Gonzalez; Francisco Fuentes; Zheng-Yuan Su; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2014-05-16       Impact factor: 4.009

10.  Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters.

Authors:  Meenakshi Sudhakaran; Michael Ramirez Parra; Hayden Stoub; Kathleen A Gallo; Andrea I Doseff
Journal:  Biochem Pharmacol       Date:  2020-10-02       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.